Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Result of AGM

December 15, 2023
RNS Number : 0572X Renalytix PLC 15 December 2023   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 15 December 2023   - Renalytix (NASDAQ: RNLX)  (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical

Directorate Change

December 8, 2023
RNS Number : 2472W Renalytix PLC 08 December 2023   Renalytix plc ("Renalytix" or the "Company")   Directorate Change   LONDON and SALT LAKE CITY -   December 8, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

Grant of Share Options

November 23, 2023
RNS Number : 3917U Renalytix PLC 23 November 2023   Renalytix plc ("Renalytix" or the "Company")   Grant of Share Options   LONDON and SALT LAKE CITY -   November 23, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

Publication of Annual Report 2023 & Notice of AGM

November 17, 2023
RNS Number : 8806T Renalytix PLC 17 November 2023     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2023 and Notice of 2023 Annual General Meeting   LONDON and SALT LAKE CITY, UT November, 17 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual

Renalytix Reports Financial Results for Q1 FY2024

November 14, 2023
RNS Number : 3099T Renalytix PLC 14 November 2023   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024   LONDON and SALT LAKE CITY , November 14, 2023   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial

Notice of Results

November 7, 2023
RNS Number : 5522S Renalytix PLC 07 November 2023     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14   LONDON and SALT LAKE CITY , November 7, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it

Announcement of AGM and Publication of AR

October 30, 2023
RNS Number : 7470R Renalytix PLC 30 October 2023     Renalytix plc ("Renalytix" or the "Company")   Announcement of AGM and Publication of Annual Report 2023   LONDON and SALT LAKE CITY, UT   October 30, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that its Annual General Meeting

Directorate change

October 24, 2023
RNS Number : 0376R Renalytix PLC 24 October 2023   Renalytix plc ("Renalytix" or the "Company")   Directorate change   LONDON and SALT LAKE CITY -   October 24, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , the first company to commercialize an FDA authorized artificial intelligence (AI)

Issue of Shares

October 17, 2023
RNS Number : 3030Q Renalytix PLC 17 October 2023   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   October 17, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the Company's convertible bond, further

US Patent Office Allows Patent Claims for IP

October 6, 2023
RNS Number : 8892O Renalytix PLC 06 October 2023     Renalytix plc ("Renalytix" or the "Company")   US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix   LONDON and SALT LAKE CITY -   October 6, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX), the
Displaying 71 - 80 of 347